immunoglobulin

Omalizumab 是针对人免疫球蛋白 E 的重组人源化单克隆抗体(KD:0.393 nM)。它能够结合人 FcγRIIb 受体(KD:6.37 uM)。它对持续性过敏性哮喘具有潜在的研究价值。

Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) 是一种由小鼠来源，针对大鼠 κ Immunoglobulin Light Chain 的 IgG2a, κ 型抗体抑制剂。

Immunoglobulin M heavy chain (IGHM) fragment [Homo sapiens] is a fragment (Gly-Val-Ala-Leu-His-Arg-Pro-Asp-Val-Tyr-Leu-Leu-Pro-Pro-Ala-Arg) on the human immunoglobulin micro heavy chain. Immunoglobulins (Ig) are the antigen recognition molecules of B cell

Immunoglobulin light chain variable region fragment [Homo sapiens] is a fragment (Phe-Thr-Leu-Lys-Ile-Ser-Arg) on the variable region of the human immunoglobulin light chain.

Immunoglobulin light chain variable region fragment [Homo sapiens] [Mus musculus] is a fragment on the variable region of the human and mouse immunoglobulin light chain. Immunoglobulins (Ig) are the antigen recognition molecules of B cells. An Ig molecule

Denosumab 是能够结合并抑制RANKL 受体激活因子的人单克隆抗体。它具有抗癌活性，可降髋部、低椎骨以及非椎骨骨折的风险。

Aducanumab (BIIB037)，一种选择性人免疫球蛋白γ-1（IgG1）单克隆抗体，靶向β淀粉样蛋白 (Aβ) 的聚集形式。Aducanumab 显示出脑渗透性，可用于治疗阿尔茨海默病 (AD) 。

RMP1-14 是一种 IgG 样免疫球蛋白抗小鼠 PD-1 抗体，可阻断 PD-1 PD-L1 信号传导；其同型对照抗体为Mouse IgG2a kappa, Isotype Control。

AVP-13358是一种CD23拮抗剂（免疫球蛋白ε-Fc 受体拮抗剂），一种免疫球蛋白E 抑制剂。AVP-13358对IgE、细胞因子和CD23有强效活性 ，可用于治疗免疫系统疾病、感染和耳鼻喉科疾病。

Laflunimus(HR325,拉氟莫司)是一种DHODH (二氢硼酸脱氢酶) 抑制剂，在体外和体内均能抑制免疫球蛋白IgM和IgG的分泌，IC50=2.5 μm，通过干扰嘧啶代谢发挥免疫抑制作用，可用于研究神经痛。

Reslizumab (Sch 55700) 是一种人源化免疫球蛋白 G （IgG）4 κ 单克隆抗体，可与人白细胞介素 5 结合，从而减少嗜酸性粒细胞的产生和存活。Reslizumab 可改善肺功能，可诱导嗜酸性粒细胞的产生和成熟减少，可用于研究哮喘。

SIRT-IN-5，一种SIRT3抑制剂，具有2.88 μM的IC50值。该化合物能够促进多发性骨髓瘤细胞的分化，并导致分化抗原CD49e以及人免疫球蛋白轻链λ和κ的表达上升。

IgG has four forms, provides the majority of antibody-based immunity against invading pathogens. The only antibody capable of crossing the placenta to give passive immunity to the fetus. Eliminates pathogens in the early stages of B cell-mediated (humoral

KF38789 特异性的抑制P-selectin 与PSGL-1结合。它对 U937 细胞与 P-selectin 免疫球蛋白 G 嵌合蛋白 (P-selectin-Ig) 的结合具有抑制作用 (IC50:1.97 μM) 。

Andolast, also known as CR-2039, an anti-allergic agent for the treatment of bronchial asthma, chronic obstructive pulmonary disease (COPD). Andolast acts at different cellular levels to inhibit immunoglobulin E synthesis. Andolast proved to be significan

Ro 19-1400, a platelet-activating factor antagonist, directly inhibits immunoglobulin E-dependent mediator release.

BiP inducer X (BIX) 是免疫球蛋白重链结合蛋白 (BiP) GRP78 的选择性诱导剂和 ER 伴侣诱导剂。 BiP inducer X 可防止神经元和视网膜细胞系中的细胞死亡。

Igercine is the C-terminal nonapeptide in immunoglobulin E.

Tiragolumab(MTIG-7192A) 是一种靶向 T 细胞免疫球蛋白和 ITIM 结构域 (TIGIT) 的单克隆抗体。Tiragolumab (anti-TIGIT) 常与 PD-L1 抑制剂 Atezolizumab 联合使用用来治疗像非小细胞肺癌类的实体恶性肿瘤。

Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina. It is anionic and found mainly on the inner leaflet of the cell membrane. It is biosynthesized from phosphatidylcholine or phosphatidylethanolamine by phosphatidyl synthase 1 (PSS1) or PSS2, respectively, in the endoplasmic reticulum and can be reversibly converted back by the same enzymes. It can also be irreversibly converted to phosphatidylethanolamine by phosphatidylserine decarboxylase in the mitochondria. Phosphatidylserine binds to T cell immunoglobulin mucin type 1 (TIM-1) and TIM-4 receptors as well as brain-specific angiogenesis inhibitor 1 (BAI1), leading to anti-inflammatory and anti-atherosclerotic effects. It is also a cofactor involved in the activation of various signaling pathways through activation of protein kinase C, neutral sphingomyelinase, and c-Raf-1 protein kinase among others. Phosphatidylserine is externalized during apoptosis by scramblases in the plasma membrane as a signal for phagocytes to engulf the cell. Phosphatidylserines (bovine) is a mixture of bovine phosphatidylserines containing fatty acids with variable chain lengths at the sn-1 and sn-2 positions.

C24:1 3'-sulfo Galactosylceramide (d18:1 24:1(15Z))是成熟髓鞘中主要的硫酸盐类化合物。C24:1 3'-sulfo Galactosylceramide (d18:1 24:1(15Z)) 在大鼠小脑中发现活跃的髓发生鞘化反应时积累率高于C24 3'-sulfo 半乳糖甘油酰胺。C24:1 3'-sulfo Galactosylceramide (d18:1 24:1(15Z))与C 型凝集素和免疫球蛋白样受体相互作用使对LMIR5的亲和力高。C24:1 3'-sulfo Galactosylceramide (d18:1 24:1(15Z))诱导嗜碱细胞产生MCP-1，可通过增加LMIR5激活NFAT，但不能诱导肥大细胞 。C24:1 3'-sulfo Galactosylceramide (d18:1 24:1(15Z))在体外与CD1d 结合，并增加游离小鼠脾细胞的增殖。

Rozanolixizumab（RYSTIGGO）是一种针对人类新生儿 Fc 受体（FcRn）的高亲和力人源化免疫球蛋白 G4 单克隆抗体，用于研究自身免疫和同种免疫疾病中致病性 IgG 。

hIgG–hFc receptor-IN-1 是一种人免疫球蛋白G -人新生儿Fc 受体(hIgG-hFcRn)蛋白-蛋白相互作用抑制剂 (IC50: 2 μM)。

LC kinetic stabilizer-1 为一种高效、选择性的淀粉样免疫球蛋白轻链动力学稳定剂，对 WIL-FL* 与 WIL-FL*T46L F49Y 的EC50值分别为140 nM与74.1 nM。其中，WIL-FL 为一种淀粉样变FL-LC二聚体。